Wealthspire Advisors (Maryland)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$490K Sell
6,144
-1,175
-16% -$91.7K 0.02% 275
2020
Q2
$506K Buy
7,319
+221
+3% +$15.7K 0.04% 256
2020
Q1
$446K Buy
7,098
+72
+1% +$5.19K 0.04% 250
2019
Q4
$546K Sell
7,026
-108
-2% -$8.43K 0.04% 268
2019
Q3
$523K Buy
7,134
+105
+1% +$7.38K 0.04% 254
2019
Q2
$433K Sell
7,029
-123
-2% -$7.44K 0.03% 279
2019
Q1
$456K Buy
7,152
+1,794
+33% +$102K 0.03% 268
2018
Q4
$274K Buy
5,358
+537
+11% +$27.2K 0.02% 343
2018
Q3
$280K Sell
4,821
-813
-14% -$39.8K 0.02% 380
2018
Q2
$273K Sell
5,634
-2,952
-34% -$138K 0.02% 385
2018
Q1
$399K Sell
8,586
-732
-8% -$31.8K 0.04% 295
2017
Q4
$350K Buy
9,318
+3,645
+64% +$134K 0.03% 337
2017
Q3
$207K Buy
5,673
+687
+14% +$26.2K 0.02% 462
2017
Q2
$197K Buy
4,986
+2,970
+147% +$108K 0.02% 455
2017
Q1
$63K Buy
2,016
+129
+7% +$4.04K 0.01% 740
2016
Q4
$59K Sell
1,887
-234
-11% -$7.58K 0.01% 724
2016
Q3
$85K Buy
2,121
+93
+5% +$3.5K 0.01% 623
2016
Q2
$67K Buy
2,028
+510
+34% +$17.4K 0.01% 649
2016
Q1
$45K Sell
1,518
-51
-3% -$1.41K 0.01% 728
2015
Q4
$41K Buy
+1,569
New +$40.7K 0.01% 772

Other funds holding EW

Wealthspire Advisors (Maryland)'s EW Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) reduced its Edwards Lifesciences (EW) stake by 16% in Q3 2020, selling an estimated $91.7K and leaving 6,144 shares worth $490K. The position accounts for 0.02% of the portfolio, ranked #275.

Wealthspire Advisors (Maryland) first reported a position in EW in Q4 2015 and has held it in 20 quarters since. The position peaked at $546K in Q4 2019. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 6,144 shares of Edwards Lifesciences worth $490K as of Q3 2020.
  • Wealthspire Advisors (Maryland) sold 1,175 Edwards Lifesciences shares in Q3 2020, an estimated $91.7K.
  • Edwards Lifesciences made up 0.02% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #275 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Edwards Lifesciences in Q4 2015 and has held it in 20 quarters since.
  • Wealthspire Advisors (Maryland)'s Edwards Lifesciences position peaked at $546K in Q4 2019.
  • 1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.